2021-12-31-accounts

				Page
Report ofthe Trustees			1	to	4
Independent Examiner's	Report
Statement ofFinancial	Activities
Balance Sheet
Cash Flow Statement
Notes to the Cash Flow	Statement
Notes to the Financial Statements			10 to		14
Detailed Statement ofFinancial		Activities		15

		Unrestricted	Restricted	Total
		fund	funds	funds
	Notes		5
INCOME AND ENDOWMENTS FROM
Donations and legacies		550%244	293%257	843,501
Other trading activities Investment income		398,348 383	1,412	399,760 383
Total		948%975	294,669	1,243,644
EXPENDITURE ON
Raising funds		292%896		292,896
Charitable activities
Medical Equipment Costs		338,253	466,334	804%587
Other		2,100		2,100
Total		633,249	466434	1,099,583
NET INCOME/(EXPENDITURE)		315%726	(171,665)	144,061
Transfers between funds	12	(245392)	245,392
Net movement in funds		70,334	73727	144,061
TOTAL FUNDS CARRIED FORWARD		70434	73%727	144,061

		Unrestricted	Restricted	Total
		fund	funds	funds
	Notes	6	6
CURRENT ASSETS
Debtors	10	222,874	6,600	229)474
Cash at bank		651,602	385,261	1,036,863
		874,476	391,861	1,2661337
CREDITORS
Amounts falling due within one year		(804,142)	(318,134)	(1,122,276)
NET CURRENT ASSETS		70,334	73.727	144i061
TOTAL ASSETSLESS CURRENT
LIABILITIES		70,334	73,727	144,061
NET ASSETS		70,334	73,727	144,061
FUNDS	l2
Unrestricted funds				70434
Restricted funds				73727
TOTAL FUNDS				144,061

				Notes
Cash flaws from operating	activities
Cash generated from operations					1,036,480
Net cash provided by operating		activities			Ii036480
Cash flows from investing	activities
Interest received					383
Net cash provided by investing		activities			383
Change in cash and cash the reporting period	equivalents		in		1,036,863
Cash and cash equivalents	at	the
beginning ofthe reporting	period
Cash and cash equivalents	at	the end	of
the reporting period					1,036,863

RECONCILIATION	RECONCILIATION	OFNET INCOME TO NKT CASH FLOW FROM OPERATING ACTIVITIES	OFNET INCOME TO NKT CASH FLOW FROM OPERATING ACTIVITIES	OFNET INCOME TO NKT CASH FLOW FROM OPERATING ACTIVITIES
				8
Net income for the Activities)	reporting		period (as per the Statement ofFinancial	144,061
Adjustments for:
Interest received				(383)
Increase in debtors				(229,474)
Increase in creditors				1,122,276
Net cash provided	by	operations		1,036,480

ANALYSIS OF CHANGES IN NET	FUNDS
	At 27/I I/20	Cash flow 6	At 31/12/21 f
Net cash
Cash at bank		1,036,863	1,036,863
		1,036,863	1,036,863
Total		1,036,863	1,036,863

6.	CHARITABLE ACTIVITIES COSTS	CHARITABLE ACTIVITIES COSTS	CHARITABLE ACTIVITIES COSTS
						Direct
						Costs
	Medical Equipment Costs					804,587
7.	SUPPORT COSTS
					Governance
				Finance	costs	Totals
					g
	Raising donations and legacies Other resources expended			305896 900	1,200	30,896 2,100
				31,796	1,200	32,996
8.	TRUSTEES' REMUNERATION		AND BENEFITS
	There were no trustees'	remuneration	or other benefits for the period	ended 31 December 2021.
	Trustees' expenses
	There were no trustees' expenses paid for the period ended 31December 2021.
9.	STAFFCOSTS					f
	Wages and salaries					581859
						58,859
	The average monthly	number ofemployees during the period was as		follows:
	Fundraising activities
	No employees received emoluments		in excess of660,000,
10.	DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR
	Trade debtors					227,247
	Other debtors					19071
	Prepayments and accrued income					1,156
						229,474

11.	CRKDITORS	r AMO	UNTS FALLING DUK W	ITHIN ONE YEAR
						5
	Trade creditors					I 104i452
	Social security	and other taxes				1,474
	Accruals and deferred		income			16,350
						1,122,276
12.	MOVEMENT IN FUNDS
				Net	Transfers
				movement	between	At
				in funds	funds	31/12/21
				5	f.
	Unrestricted	funds
	General fund			315,726	(245i392)	70,334
	Restricted funds
	Closure			61i000	4,000	65,000
	Andover			59		59
	2020 Dri Oct Opthlmology			(61)995)	61,995
	HGF Fund			71668		7,668
	Winchester			1,000		1,000
	2021 Paceports			(6,639)	6,639
	2021 Mat Resus			(64,878)	64,878
	Drug Storage			(2,880)	2,880
	Urogolgy Laser			(105,000)	105i000
				(171i665)	245,392	73i727
	TOTAL FUNDS			144,061		144,061

Net movement in funds, included	Net movement in funds, included	in the above are as follows:
			Incoming	Resources	Movement
			resources	expended	in funds
					6
Unrestricted funds
General fund			948,975	(633)249)	315)726
Restricted funds
Dig Deep Covid Emergency	Fund		4,188	(4,188)
Closure			61,000		61%000
Andover			59		59
2020 Radiology - Elastography			62,500	(62,500)
20208iometry for Opthoalmology			45,393	(45,393)
2020 Iqoro Training Device			11,600	(11,600)
2020 Dri Oct Opthlmology			3,000	(64,995)	(61,995)
HGF Fund			7,668		7,668
2020 Hologic Horizon Scanner			50,000	(50,000)
Winchester			1,000		1,000
2021 Paceports			7,361	(14,000)	(6,639)
2021 Mat Resus			40,400	(105878)	(64)878)
Drug Storage				(2,880)	(2,880)
Urogolgy Laser				(105,000)	(105,000)
Dermoscopy			500	(500)
			294,669	(466,334)	(171,665)
TOTAL FUNDS			1,243,644	(1,099,583)	144,061

INCOME AND ENDOWMENTS	INCOME AND ENDOWMENTS	INCOME AND ENDOWMENTS
Donations and legacies
Donations			843,401
Legacies			100
			843,501
Other trading activities
Fundraising events			399,760
Investment income
Deposit account interest			383
Total incoming resources			1,243,644
EXPENDITURE
Raising donations	and legacies
Wages			58,859
Event expenses			203,141
			262,000
Charitable activities
Medical equipment	costs		804,587
Support costs
Finance
Office costs			27,197
Bank charges			2,510
General expenses			2,089
			31,796
Governance costs
Independent examiner's		fees	1,200
Total resources expended			1,099,583
Net income			144,061